Generation of Arctic-like Rabies Viruses Containing Chimeric Glycoproteins Enables Serological Potency Studies.

Preprint OPEN
Bentley, Emma; Ali, Ruqiyo; Horton, Daniel; Corti, Davide; Banyard, Ashley; Fooks, Anthony; Wright, Edward;

Rabies viruses have the highest case fatality rate of any known virus and are responsible for an estimated 60,000 deaths each year. This is despite the fact that there are highly efficacious vaccines and post-exposure prophylaxis available. However, while it is assumed ... View more
  • References (43)
    43 references, page 1 of 5

    Bakker, A. B. H., Python, C., Kissling, C. J., Pandya, P., Marissen, W. E., Brink, M. F., Lagerwerf, F., Worst, S., van Corven, E. & other authors. (2008). First administration to humans of a monoclonal antibody cocktail against rabies virus: Safety, tolerability, and neutralizing activity. Vaccine 26, 5922-5927.

    Bakker, A. B. H., Marissen, W. E., Arjen, R., Rice, A. B., Weldon, W. C., Niezgoda, M., Hanlon, C. a, Thijsse, S., Backus, H. H. J. & other authors. (2005). Novel Human Monoclonal Antibody Combination Effectively Neutralizing Natural Rabies Virus Variants and Individual In Vitro Escape Mutants Novel Human Monoclonal Antibody Combination Effectively Neutralizing Natural Rabies Virus Variants and Individual In. J Virol 79, 9062-9068.

    Banyard, A. C., Horton, D. L., Freuling, C., Müller, T. & Fooks, A. R.(2013). Control and prevention of canine rabies: the need for building laboratory-based surveillance capacity. Antiviral Res 98, 357-64. Elsevier B.V.

    Banyard, A. C. & Fooks, A. R. (2017). The impact of novel lyssavirus discovery. Microbiol Aust 38, 17-21.

    De Benedictis, P., Minola, A., Nodari, E. R., Aiello, R., Zecchin, B., Salomoni, A., Foglierini, M., Agatic, G., Vanzetta, F. & other authors. (2016). Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxis. EMBO Mol Med 8, 407-421.

    Bresson, J.-L., Perronne, C., Launay, O., Gerdil, C., Saville, M., Wood, J., Höschler, K. & Zambon, M. C. (2006). Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial. Lancet 367, 1657-64.

    Brookes, S. M., Parsons, G., Johnson, N., McElhinney, L. M. & Fooks, a R. (2005). Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses. Vaccine 23, 4101-9.

    Carpentier, D. C. J., Vevis, K., Trabalza, A., Georgiadis, C., Ellison, S. M., Asfahani, R. I. & Mazarakis, N. D. (2011). Enhanced pseudotyping efficiency of HIV-1 lentiviral vectors by a rabies/vesicular stomatitis virus chimeric envelope glycoprotein. Gene Ther 19, 761-74. Nature Publishing Group.

    Ceballos, N. A., Morón, S. V., Berciano, J. M., Nicolás, O., López, C. A., Juste, J., Nevado, C. R., Setién, Á. A. & Echevarría, J. E. (2013). Novel lyssavirus in bat, Spain. Emerg Infect Dis 19, 793-795.

    Condit, R. C. (2001). Principles of Virology. In Fields Virol, 4th edn., pp. 19-51. Edited by D. M. Knipe & P. M. Howley. Philadelphia: Lippincott Williams & Wilkins.

  • Related Research Results (3)
  • Similar Research Results (3)
  • Metrics
    No metrics available
Share - Bookmark

  • Download from
    bioRxiv via bioRxiv (Preprint, 2017)
  • Cite this publication